Oral JAK Inhibitor Use in Atopic Dermatitis: Screening and Monitoring Patients

Opinion
Video

Medical experts discuss the patient screening process for oral JAK inhibitors and identify absolute or relative contraindications.

Video content above is prompted by the following:

  1. How do you screen patients for whom you are considering use of an oral JAK inhibitor?
  2. What results would you consider absolute or relative contraindications to the use of JAK inhibitors (Samuel 2023)?
Recent Videos
Julie Harper, MD: Discussing Acne Treatment Updates, Unmet Needs Among Patients
Discussing Unmet Needs Among Patients in Dermatology, with Matthew Zirwas, MD
Review of Recent Advancements in Dermatology, with Matthew Zirwas, MD
Allison Moser, MSN, RN, FNP-BC | Credit: Allison Moser on LinkedIn
Raj Chovatiya, MD, PhD: Treating Hidradenitis Suppurativa with IL-17, JAK Inhibitors
Most Promising New Drugs for Hidradenitis Suppurativa, with Raj Chovatiya, MD, PhD
Lucy Mathew, NP
Lavinia Iordache, PA
HCPLive Five at ESC 2024 | Image Credit: HCPLive
A panel of 3 experts on atopic dermatitis
© 2024 MJH Life Sciences

All rights reserved.